Hipocalcemia en el período neonatal y la infancia

[1] A.K. Campbell, “Calcium as an intracellular regulator,” Proceedings of the Nutrition Society, vol. 49, no. 1, pp. 51–56, 1990.

[2] M. D. Bootman, T. J. Collins, C. M. Peppiatt et al., “Calcium signalling—an overview,” Seminars in Cell & Developmental Biology, vol. 12, no. 1, pp. 3–10, 2001.

[3] L. Wang, G. H. Nancollas, Z. J. Henneman, E. Klein, and S. Weiner, “Nano sized particles in bone and dissolution insensitivity of bone mineral,” Bio interphases, vol. 1, no. 3, pp. 106–111, 2006.

[4] J. Singh, N. Moghal, S. H. S. Pearce, and T. Cheetham, “The investigation of hypocalcaemia and rickets,” Archives of Disease in Childhood, vol. 88, no. 5, pp. 403–407, 2003.

[5] W. G. Robertson and R. W. Marshall, “Calcium measurements in serum and plasma–total and ionized,” Critical Reviews in Clinical Laboratory Sciences, vol. 11, no. 3, pp. 271–304, 1979.

[6] S. M. Moe, “Disorders involving calcium, phosphorus, and magnesium,” Primary Care, vol. 35, no. 2, pp. 215–237, 2008.

[7] H. Oberleithner, R. Greger, and F. Lang, “The effect of respiratory and metabolic acid-base changes on ionized calcium concentration: in vivo and in vitro experiments in man and rat,” European Journal of Clinical Investigation, vol. 12, no. 6, pp. 451–455, 1982.

[8] J. J. Freitag, K. J. Martin, M. B. Conrades et al., “Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone,” The Journal of Clinical Investigation, vol. 64, no. 5, pp. 1238–1244, 1979.

[9] J. Allgrove, “Physiology of calcium, phosphate and magnesium,” Endocrine Development, vol. 16, pp. 8–31, 2009.

[10] L. P. Rubin, J. T. Posillico, C. S. Anast, and E. M. Brown, “Circulating levels of biologically active and immunoreactive intact parathyroid hormone in human newborns,” Pediatric Research, vol. 29, no. 2, pp. 201–207, 1991.

[11] C. S. Kovacs, B. Lanske, J. L. Hunzelman, J. Guo, A. C. Karaplis, and H. M. Kronenberg, “Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a

receptor distinct from the PTH/PTHrP receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 26, pp. 15233–15238, 1996.

[12] R. C. Tsang, I. J. Light, J. M. Sutherland, and L. I. Kleinman, “Possible pathogenetic factors in neonatal hypocalcemia of prematurity. The role of gestation, hyperphosphatemia, hypomagnesemia, urinary calcium loss, and parathormone responsiveness,” Journal of Pediatrics, vol. 82, no. 3, pp. 423–429, 1973.

[13] S. C. Hsu and M. A. Levine, “Perinatal calcium metabolism: physiology and pathophysiology,” Seminars in Fetal and Neonatal Medicine, vol. 9, no. 1, pp. 23–36, 2004.

[14] J. Oden and M. Bourgeois, “Neonatal endocrinology,” The Indian Journal of Pediatrics, vol. 67, no. 3, pp. 217–223, 2000.

[15] J. Sharma, A. Bajpai, M. Kabra, and P. S. N. Menon, “Hypocalcemia clinical, biochemical, radiological profile and follow-up in a tertiary hospital in India,” Indian Pediatrics, vol. 39, no. 3, pp. 276–282, 2002.

[16] P. S. Venkataraman, R. C. Tsang, I.-W. Chen, andM. A. Sperling, “Pathogenesis of early neonatal hypocalcemia: studies of serum calcitonin, gastrin, and plasma glucagon,” Journal of Pediatrics, vol. 110, no. 4, pp. 599–603, 1987.

[17] R. E. Behrman, R. C. Tsang, I. Chen et al., “Neonatal hypocalcemia in infants with birth asphyxia,” Journal of Pediatrics, vol. 84, no. 3, pp. 428–433, 1974.

[18] R. C. Tsang, R. Strub, D. R. Brown, J. Steichen, C.Hartman, and I.-W. Chen, “Hypomagnesemia in infants of diabetic mothers: perinatal studies,” Journal of Pediatrics, vol. 89, no. 1, pp. 115–119, 1976.